2023.10.10
Dr. Pengcheng Zhou Joins Cure Genetics as Vice Pre...
Cure Genetics is delighted to announce that Dr. Pengcheng Zhou has joined the company on August 21, 2023, taking on the role of Vice President of Gene Therapy Research and Development, responsible for the research and translation of the company's gene therapy products. Dr. Zhou brings with him decades of extensive experience in the AAV gene therapy domain, showcasing remarkable achievements at leading academic institutions and renowned companies including Harvard University, Voyager, Luye Pharma, and Frontera Therapeutics.
